Product image of Gosall (Bilastine) supplied by GNH India

Gosall

Active Ingredient:
Bilastine
Origin:
EU

Gosall (Bilastine)

Gosall is an oral formulation that contains the second‑generation antihistamine bilastine. It is marketed in the European Union and is classified as a selective peripheral H1‑receptor antagonist. The product is intended for the relief of allergic symptoms and is supplied without a specified strength or dosage form in this description.

Manufacturer / TM Owner

Menarini International Operations Luxembourg S.A.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Gosall is indicated for the management of allergic conditions that involve histamine release. It is commonly prescribed for the following clinical situations:

  • Seasonal or perennial allergic rhinitis
  • Chronic idiopathic urticaria (hives)
  • Allergic conjunctivitis associated with rhinitis
  • Relief of itching, sneezing, and nasal congestion caused by allergens
  • Adjunct therapy for other histamine‑mediated skin reactions

Side Effects

Side effects of bilastine are generally mild, but patients should be aware of both common and less frequent reactions.

Common

  • Headache
  • Dry mouth
  • Fatigue or drowsiness (rare for second‑generation antihistamines)
  • Nausea
  • Dizziness

Serious

  • Severe skin rash or Stevens‑Johnson syndrome
  • Anaphylactic reactions such as swelling of the face, lips, or throat
  • Cardiac arrhythmias (very rare)
  • Persistent tachycardia

Precautions & Warnings

Before using Gosall, consider the following safety points:

  • Assess renal or hepatic impairment, as dose adjustment may be required.
  • Use caution in pregnant or breastfeeding individuals; consult a healthcare professional.
  • Avoid driving or operating machinery if you experience dizziness.
  • Monitor for signs of allergic reactions despite the antihistamine effect.
  • Review all concomitant medications for potential interactions.
  • Discontinue use and seek medical advice if serious skin reactions develop.

Avoid Interactions

Bilastine may interact with several drug classes. Understanding which combinations to avoid or use cautiously can help maintain safety.

Avoid

  • Antifungal agents such as ketoconazole and itraconazole, which can increase bilastine plasma levels.
  • Certain macrolide antibiotics (e.g., erythromycin) that affect P‑glycoprotein transport.
  • Strong CYP3A4 inhibitors, although bilastine is not primarily metabolized by CYP enzymes, they may still affect absorption.

Use with caution

  • Alcohol, which can enhance sedation.
  • Other antihistamines or sedating medications, potentially increasing drowsiness.
  • Food high in fat, as it may reduce bilastine absorption.
  • Medications that prolong the QT interval, especially in patients with cardiac risk factors.

Frequently Asked Questions

Gosall is an oral antihistamine that contains bilastine, a second‑generation H1‑receptor antagonist used to treat allergic conditions.

Gosall is commonly used for allergic rhinitis, chronic idiopathic urticaria, and related symptoms such as sneezing, itching, and nasal congestion.

Bilastine selectively blocks peripheral H1 histamine receptors, preventing histamine from triggering the typical allergic response.

Bilastine is a second‑generation antihistamine and is generally non‑sedating, though occasional mild drowsiness can occur.

Patients with renal impairment should discuss dosage adjustments with a healthcare professional, as bilastine clearance may be reduced.

The safety of bilastine in pregnancy has not been fully established; pregnant or breastfeeding individuals should consult their doctor before use.

Common side effects include headache, dry mouth, nausea, dizziness, and occasional mild fatigue.

Signs such as severe skin rash, swelling of the face or throat, difficulty breathing, or rapid heartbeat require urgent medical care.

High‑fat meals can reduce bilastine absorption, so it is generally recommended to take the medication on an empty stomach or with a light meal.

Bilastine should be avoided with strong P‑glycoprotein inhibitors like ketoconazole or itraconazole, and caution is advised when combined with macrolide antibiotics.

Most people do not experience significant sedation, but if dizziness or drowsiness occurs, it is safest to avoid driving or operating heavy equipment.

Bilastine typically begins to relieve allergy symptoms within 1 to 3 hours after oral administration.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.